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Abstract
Background: acantholytic squamous cell carcinomas (ASCC) and intraoral angiosarcoma share
similar histopathological features. Aim of this study was to find marker for a clear distinction.
Methods: Four oral acantholytic squamous cell carcinomas and one intraoral angiosarcoma are
used to compare the eruptive intraoral growth-pattern, age-peak, unfavourable prognosis and slit-
like intratumorous spaces in common histological staining as identical clinical and histopathological
features. Immunohistochemical staining for pancytokeratin, cytokeratin, collagen type IV, γ2-chain
of laminin-5, endothelial differentiation marker CD31 and CD34, F VIII-associated antigen, Ki 67-
antigen, β-catenin, E-cadherin, α-smooth-muscle-actin and Fli-1 were done.
Results: Cytokeratin-immunoreactive cells can be identified in both lesions. The large
vascularization of ASCC complicates the interpretation of vascular differential markers being
characteristic for angiosarcoma. Loss of cell-cell-adhesion, monitored by loss of E-cadherin and β-
catenin membrane-staining, are indetified as reasons for massive expression of invasion-factor ln-5
in ASCC and considered responsible for unfavourable prognosis of ASCC. Expression of Fli-1 in
angiosarcoma and cellular immunoreaction for ln-5 in ASCC are worked out as distinguishing
features of both entities.
Conclusion: Fli-1 in angiosarcoma and ln-5 in ASCC are distinguishing features.
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Both oral angiosarcoma and oral acantholytic squamous
cell carcinoma (ASCC) are well-defined entities. The
WHO classification of tumours describes angiosarcoma as
a malignant tumour consisting of cells recapitulating var-
iably the morphological and functional features of nor-
mal endothelium, ICD-O code 9120/3 [1-3]. ASCC
(synonyms: acantholytic squamous cell carcinoma, ade-
noid squamous carcinoma, pseudoglandular squamous
cell carcinoma, squamous cell carcinoma with glandlike
(adenoid) features, angiosarcoma-like squamous cell car-
cinoma, adenoacanthoma, pseudovascular adenoid squa-
mous cell carcinoma, pseudoangiosarcomatous
carcinoma) is characterized as a squamous cell carcinoma
containing pseudo-glandular spaces or lumina, ICD-O
code 8075/3 [4,5].
Although angiosarcoma (malignant soft tissue tumour)
and ASCC present conceptually complete different
tumour entities their histological features are similar and
defined by intratumorous spaces. Interestingly both
tumour entities show comparable clinical appearance in
the oral cavity. The peak incidence of angiosarcoma is the
7th decade [6] and the peak incidence of the oral ASCC is
the 6th decade [7]. Macroscopically both entities express in
oral cavity fast growing, eruptive lesions and have poor
prognosis [8,9]. Like all oral squamous cell carcinomas
ASCC show male predilection of 1 to 3.5 whereas no sex
predilection of oral angiosarcoma is known.
Common and different aspects of oral angiosarcoma and
ASCC will be worked out for the correct differential diag-
nosis. The cellbiological background explaining the pecu-
liar pseudovascular appearance of ASCC is elucidated.
Methods
Clinical features
A 63-year-old male patient presented with a polypous,
superficial ulcerated, 1.5 × 1 × 1 cm3 large mass at the alve-
olar ridge. A biopsy was taken and the histological diagno-
sis of an angiosarcoma was established. Metastases
developed in pleurae (cytologically verified) and ileum
one month after diagnosis of the primary oral lesion.
Although an ileum segment resection was carried out the
patient died of angiosarcoma induced intestinal bleeding
two months after initial diagnosis.
The clinical data of the ASCC are summarized in table 1.
With the exception of case 3 which represents a meta-
chronical ASCC after multimodal therapy of a hypopha-
ryngeal squamous cell carcinoma all ASCC were
diagnosed in an advanced stage. Case 1 developed
regional lymph node and distant metastases during adju-
vant radiotherapy (Figure. 1).
Methods
For comparative analysis the tissue of the diagnostic
tumour biopsies was fixed in 4.0% buffered formalin and
embedded in paraffin. The slides were stained with H&E,
PAS, Goldner's trichrome staining and Gömöri.
Immunohistochemistry
Primary antibodies applied in the study: pancytokeratin
(clones AE1/AE3, Dako, Denmark) dilution 1:20, cytoker-
atin (clone MNF-116, Dako, Denmark) dilution 1:200,
collagen type IV (clone C22, Dako, Denmark) dilution
1:200, γ2-chain of laminin-5 (clone D4B5, Chemicon,
USA) dilution 1:10000, endothelial differentiation
marker CD31 (clone JC/70A, Dako, Denmark) dilution
Exophytic growth of an oral acantholytic squamous cell carci-noma on the alveolar ridge of the l wer jawFigure 1
Exophytic growth of an oral acantholytic squamous 
cell carcinoma on the alveolar ridge of the lower jaw.
Table 1: Clinical features of patients with acantholytic squamous cell carcinoma (ASCC). 
Case Age Gender Site TNM
1 58 f right alveolar ridge of the
lower jaw
pT4 pN0 cM0 L1 V1
2 57 m right border of the tongue cT4
3 68 m tongue cT1
4 50 m floor of the mouth pT4a pN1 cM0 L1 V0
f: female, m: malePage 2 of 6
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dilution 1:500, F VIII-associated antigen (clone F 8/86,
Dako, Denmark) dilution 1:200, Ki 67-antigen (clone
MIB-1, Dako, Denmark) dilution 1:1000, β-catenin
(clone 17 C 2, Novacastra, U.K.) 1:200, E-cadherin (clone
4A2C7, Zymed, USA) dilution 1:75, α-smooth-muscle-
actin (clone 1A4, Dako, Denmark) dilution 1:400, Fli-1
(polyklonal, Zymed, USA). Primary antibodies were
detected using the streptavidin-biotin-alkaline phos-
phatase-technique (ChemMate, Dako, Denmark). The
immunohistochemical procedure was carried out at auto-




The diagnostic biopsies of both entities showed a superfi-
cial necrotic zone due to ulceration. The tumour cells were
large and showed a polygonal to epitheloid shape. There
was a highly pathologic nucleus-cytoplasm-ratio. Promi-
nent nucleoli were a continuous feature. The tumour cells
of both entities contained a fine granular PAS-positive
material within the cytoplasm. Both lesions were charac-
terized by slit-like intratumorous spaces or papillary and
pseudopapillary projections (Figure. 2). In case 3, addi-
tionally to the slit-like tumourous spaces a venular- or
glandular-like pattern was formed (Figure. 3). The
Gömöri staining revealed a discontinuous staining in the
basement membrane region at the tumour cell stroma
interface. In more solid tumour areas the Gömöri staining
demonstrated an acinar or trabecular growth pattern. A
dysplastic covering oral mucosa could not be evidenced
due to ulceration. Only in one ASCC, dyskeratosis could
be evidenced in serial sections. Hemorrhagic areas were
found in angiosarcoma as well as in ASCC.
Immunohistochemical findings
Cytokeratin-positive tumour cells were recognized in both
angiosarcoma as well as in the four ASCCs. The number of
cytokeratin-positive tumour cells in angiosarcoma was
lower than in ASCC (Figure. 4).
Ln-5-positive basement membrane region was also found
in both entities. In angiosarcoma the ln-5 immunostain-
ing of the basement membrane was regularly localized in
tumour sections beneath preexisting epithelial structures.
A cellular immunostaining of laminin-5 was restricted to
all four ASCCs (Figure. 5). Around the slit-like intratu-
morous spaces a discontinuous basement membrane
immunostaining was demonstrated in both entities.
Moreover, in association to spindle-shaped cells between
the spaces a dot-like or membranous immunostaining
was visualized using antibodies against collagen type IV.
In the stroma of both entities as well as around the slit-like
intratumorous spaces α-smooth-muscle-positive cells
were diagnosed and often a distinction between stroma
myofibroblasts or pericytes could not be made.
CD 31, CD 34 and factor VIII-associated antigen could be
found in the majority of the cells of angiosarcoma (Figure.
6). The endothelial differential markers have to be inter-
preted carefully, because in angiosarcoma not all tumour
Oral acantholytic squamous cell carcinoma: capillary and pap-illary growth pattern (H&E, ×150)Figure 2
Oral acantholytic squamous cell carcinoma: capillary 
and papillary growth pattern (H&E, ×150).
Oral acantholytic squamous cell carcinoma: venular/glandu-lar-like pa tern (H&E, ×150)Figur  3
Oral acantholytic squamous cell carcinoma: venular/
glandular-like pattern (H&E, ×150).Page 3 of 6
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ASCC a large vascularization characterized by positive
endothelial differential markers is regularly observed.
The proliferative activity did not discriminate angiosar-
coma from ASCC. The Ki 67-index reached 20%.
Fli-1 immunoreactivity was only recognized in angiosar-
coma (Figure. 7).
E-cadherin and β-catenin were found in all four ASCCs
but not in the angiosarcoma. In the majority of the
tumour cells there was an E-cadherin immunostaining in
cytoplasm and not at the cell membrane. Sometimes β-
catenin was seen not only in the cytoplasm but also
within the nucleus.
Discussion
Several authors have already emphasized the histopatho-
logic similarity of ASCC and angiosarcoma. [10-13].
Although the WHO defines ASCC as an original entity for
a long time [4,5], there are less than thirty cases of ASCCs
documented in the international literature so far [7]. Both
entities may have an association to previous exposal to
ionizing radiation [9,14]. To determine differential diag-
nosis and to differentiate ASCC from angiosarcoma an
immunohistochemical typing is required regularly,
because the epidermoid differentiation may be extremely
masked by pseudovascular proliferation. Dyskeratoses
may represent a rare pattern in ASCC. The immunohisto-
chemical analysis has to consider on the one side that in
soft tissue tumour angiosarcoma cytokeratin-positive cells
may appear and on the other side that the plentiful vessels
in the tumour stroma of ASCC are signed by endoepithe-
lial differential markers, so that the classic discriminating
differential markers cytokeratin, factor VIII-associated
antigen and others are often difficult to be interpreted.
[15-17]. The Fli-1-protein, a member of the ETS family of
DNA-binding transcription factors was recently high-
lighted as a new vascular differentiation marker [18,19].
Although Fli-1 can be also rarely identified in carcinomas
[20], ASCC is immunonegative for this marker, so that Fli-
1 can be recommended to discriminate between Angiosa-
rcoma and ASCC.
The incomplete border of pericytes represents an accepted
feature for identifying differentiation disturbed neoplastic
vessels of angiosarcoma. The pericytes are emphasized by
α-smooth-muscle-actin [6]. However the incomplete bor-
der of pericytes in structures of angiosarcoma is not suita-
ble for discriminating angiosarcoma versus ASCC,
because in ASCC α-smooth-muscle-stromamyofibrob-
lasts may mimic the pattern of pericytes lining discontin-
uously the slit-like tumour-spaces.
Interestingly in angiosarcoma ln-5 positive basal mem-
branes were recognised. Ln-5 is a characteristic protein of
epithelial basal membranes that is regularly identified in
oral mucosa and in oral squamous cell carinoma [21]. It
connects the basal membrane with the hemidesmosomes
of epithelial cells and has not been described in mesen-
chymal basal membranes so far. Because in angiosarcoma
in contrast to ASCC no cytoplasmatic marking as a sign of
Oral acantholytic squamous cell carcinoma: immunohisto-chemical demonstration f th  n-5-γ2-chainFigure 5
Oral acantholytic squamous cell carcinoma: immu-
nohistochemical demonstration of the ln-5-γ2-chain. 
Note the strong immunostaining within the cytoplasm of the 
majority of the carcinoma cells (clone D4B5, ×150).
Oral angiosarcoma: immunohistochemical demonstration of the epitheli l intermediate filament protein cyt keratin i a subset of the tu our cells (clon s AE1/AE3 ×150)Figure 4
Oral angiosarcoma: immunohistochemical demon-
stration of the epithelial intermediate filament pro-
tein cytokeratin in a subset of the tumour cells 
(clones AE1/AE3 ×150).Page 4 of 6
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ln-5 was only identified in parts of angiosarcoma local-
ized next to preexisting oral epithelia, it is suggested, that
ln-5 of the new formed basal membranes of angiosar-
coma comes from the neighbouring preexisting epithelial
structures and has only been integrated into the new
formed basal membranes of angiosarcoma.
The cytoplasmatic ln-5 detection of ASCC cells presents
on the one hand a distinguishing feature between ASCC
and angiosarcoma and on the other hand a tumour bio-
logical indicator of the unfavourable prognosis of ASCC.
An abundant detection of γ2-chain of ln-5 in carcinoma
cells is correspondingly accepted in literature as an unfa-
vourable prognostic pattern. The extracellular matrix pro-
tein stimulates invasion of carcinoma cells [22-24].
Hlubek and co-workers identified 2001 β-catenin as a
transcription-factor of laminin-γ2-chain [25]. The mem-
brane-localized β-catenin-E-cadherin-complex mediates
the cell-cell-adhesion, that is obviously disturbed in ASCC
and that is responsible for forming of the typical intercel-
lular spaces [13,26,27]. In case of a disturbed forming of
β-catenin-E-cadherin-complex at the carcinoma cell mem-
brane β-catenin liberated from cell membrane is able to
migrate into the cell nucleus, to act as a transcription-fac-
tor and to induce an overexpression of invasion-factor
laminin-γ2-chain in ASCC.
The reduced cell-cell-adhesion and the extremely
increased expression of laminin-γ2-chain are suggested as
cell biological reasons for the extreme early distant metas-
tasising of ASCC during therapy.
In summary angiosarcoma and ASCC do not only share
identical clinical features and a similar histopathological
pattern in common histological staining but also show
overlaps of cytokeratin-expression and of expression of
vascular differential markers. Expression of Fli-1 in angi-
osarcoma and cytoplasmatic immunoreaction for γ2-
chain of ln-5 in ASCC are worked out as distinguishing
features of both entities.
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